March 14, 2016
By Barbara R. Rudolph, Ph.D.; Kai Rajan
Recent advances in technology have enabled 3D printing of biocompatible parts, driving major innovations in the medical industry. At the same time, 3D bioprinting has raised a number of legal questions, including patent eligibility under Section 101. In this podcast, Finnegan attorneys Barbara R. Rudolph and Kai Rajan provide insight into intellectual property considerations for 3D bioprinting.
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in June and July 2026
August 19, 2026
At the PTAB Blog
Squires Issues Precedential Decision Clarifying Obviousness-Type Double Patenting Rejections
August 17, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in May 2026
July 31, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
Articles
Choice of Law in Patent Appeals: The Federal Circuit’s Issue-by-Issue Framework
May/June 2026
Hybrid Conference
2026 Patent Law Institute: Critical Issues & Best Practices
April 9-10, 2026
San Francisco
Panel Discussion
The Future of Legal Practice – Exploring AI in Practice and Governance
March 24, 2026
Washington, DC
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.